Fundraising Fox
Maxion Therapeutics
Cambridge, GB · Founded 2020 · 59 employees on LinkedIn · 4 known investors
Find your way into Maxion Therapeutics
Sign up to see every warm intro you have to Maxion Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Maxion Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Maxion Therapeutics develops protein and antibody therapeutics using its patented KnotBody technology, which fuses cysteine-rich miniproteins (Knottins) into antibody binding loops to target ion channels and GPCRs. It focuses on first-in-class and best-in-class treatments for diseases driven by ion channel and GPCR dysfunction, including pain, autoimmune and cardiovascular conditions.
Founders & leadership
Maxion Therapeutics was founded in 2020 by John McCafferty and Aneesh Karatt-Vellatt.
Investors · 4
.png)
How we know: General Catalyst's portfolio page · the company's own site · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: LifeArc Ventures's portfolio page · the company's own site · Not right? Tell us
Founder mafia
2 people who came through Maxion Therapeutics went on to found or lead other companies.
Frequently asked questions
- What does Maxion Therapeutics do?
- Maxion Therapeutics develops protein and antibody therapeutics using its patented KnotBody technology, which fuses cysteine-rich miniproteins (Knottins) into antibody binding loops to target ion channels and GPCRs. It focuses on first-in-class and best-in-class treatments for diseases driven by ion channel and GPCR dysfunction, including pain, autoimmune and cardiovascular conditions.
- Who founded Maxion Therapeutics?
- Maxion Therapeutics was founded by John McCafferty, Aneesh Karatt-Vellatt in 2020.
- Who are Maxion Therapeutics's investors?
- Maxion Therapeutics's investors include General Catalyst, LifeArc Ventures, Monograph Capital Partners, Solasta Ventures.
- Where is Maxion Therapeutics headquartered?
- Maxion Therapeutics is headquartered in Cambridge, GB.